control groups
[용어속성] Term
Metabolic syndrome and the risk of COVID-19 infection: A nationwide population-based case-control study
Research article
[키워드] 95% CI
95% confidence interval
acute respiratory syndrome
adjusted odds ratio
age
case-control study
Cohort
cohort study
component
control group
control groups
coronavirus
COVID-19
COVID-19 group
COVID-19 infection
COVID-19 pandemic
Endpoint
higher risk
individual
inflammatory disease
insulin resistance
investigated
metabolic syndrome
Nationwide cohort study
obesity
Patient
patients
positive
Prevalence
risk
risk of COVID-19
SARS-CoV-2
SARS-CoV-2 positivity
SARS-CoV-2 test
severe COVID-19
Severe COVID-19 Infection
severity of COVID-19
significant increase
significantly
subject
with COVID-19
[DOI] 10.1016/j.numecd.2021.05.016 [Article Type] Research article
[DOI] 10.1016/j.numecd.2021.05.016 [Article Type] Research article
Use of traditional Chinese medicine as an adjunctive treatment for COVID-19 A systematic review and meta-analysis
COVID-19에 대한 보조 치료법으로 전통 의약을 사용하여 체계적인 검토 및 메타 분석
Meta-Analysis
[키워드] 95% CI
95% CIs
95% confidence interval
adjunctive treatment
calculated
Chinese
clinical study
Combined
Combined therapy
control group
control groups
Controlled trial
coronavirus disease
Coronavirus disease 2019
cough
COVID-19
COVID-19 patients
database
disappearance rate
Effect
effective
Efficacy
Efficacy and safety
evaluate
fatigue
Fever
group
integration
Intervention
involved
mean difference
Meta-analysis
Methodological quality
NOS
Odds ratio
Patient
Randomized controlled trials
reduction
required
scale
searched
significantly
sputum production
Stata
Symptom
systematic review
TCM
therapy
Traditional Chinese medicine
treated
treating COVID-19
Treatment
treatment for COVID-19
treatment of COVID-19
Trial
were used
[DOI] 10.1097/MD.0000000000026641 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1097/MD.0000000000026641 PMC 바로가기 [Article Type] Meta-Analysis
Efficacy of Different Types of Therapy for COVID-19: A Comprehensive Review
Review
[키워드] affected
Analysis
analyzed
Antiviral
antiviral drug
antiviral therapy
Clinical improvement
Comprehensive
conditions
control groups
Coronavirus infection
COVID-19
Critical
Cytokines
Data analysis
decrease
Dexamethasone
disease
Efficacy
immune
immune therapy
immunosuppressive
intravenous immunoglobulin IgG
Mortality
mortality rate
New coronavirus
not differ
Patient
patients with COVID-19
plasma
regimen
review
SARS-CoV-2
shown
significantly
Standard therapy
target
therapy
treated
Treatment
Type
viral life cycle
[DOI] 10.3390/life11080753 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/life11080753 PMC 바로가기 [Article Type] Review
Effect of Physician-Delivered COVID-19 Public Health Messages and Messages Acknowledging Racial Inequity on Black and White Adults’ Knowledge, Beliefs, and Practices Related to COVID-19 A Randomized Clinical Trial
Randomized Controlled Trial
[키워드] Adults
affected
age
assigned
black
center
clinical
Community
conducted
Control
control group
control groups
COVID-19
COVID-19 knowledge
Critical
described
determine
Effect
effective
Effectiveness
eligible
evaluate
Final
finding
Gender
greater
groups
Health
Importance
IMPROVE
incidence rate
individual
information
intervention group
knowledge
less
Masks
measure
message
not differ
objective
participant
physician
Placebo
Point
Practice
prevention
Protective
Public
randomization
randomized clinical trial
Randomly
receive
recorded
Registration
Relevance
Result
screened
setting
social distancing
statistically significant
Symptoms
the disease
treatment group
Volunteer
white
women
[DOI] 10.1001/jamanetworkopen.2021.17115 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1001/jamanetworkopen.2021.17115 PMC 바로가기 [Article Type] Randomized Controlled Trial
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial
Review
[키워드] ABG, Atrial blood gas
Analysis
Arbidol
assigned
Chest CT scans
Clinical improvement
clinical trial
Committee
conducted
Control
control group
control groups
COVID-19
COVID-2019, Coronavirus Disease 2019
Cox regression model
dose
effective
Effectiveness
Efficacy
Ethics
evaluate
GCS, Glasgow Coma Scale
hazard
Hospitalized
hospitalized patient
HR, hazard ratio
ICU, Intensive care unit
Infection
injection
Intervention
intervention group
ITT population
legally authorized representatives
LFT, liver function test
median
Medical Sciences
moderate
moderate-severe
Mortality
non-ICU patient
Open-label
participant
Patient
positive
positive RT-PCR
Prognosis
Randomized
randomized clinical trial
Randomly
Ratio
receive
Registered
Result
SARS-CoV-2
SARS-CoV-2, severe acute respiratory syndrome coronavirus2
severe COVID-19
Severe patient
single-center
statistically significant
statistically significant difference
Subcutaneous
time
treat
treated
Treatment
treatment group
Trial
TTCI
TTCI, Time to clinical improvement
two group
umifenovir
university
VBG, Venous blood gas
[DOI] 10.1016/j.intimp.2021.107969 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2021.107969 PMC 바로가기 [Article Type] Review
Serum triglyceride levels and related factors as prognostic indicators in COVID‐19 patients: A retrospective study
Original Article
[키워드] 95% confidence interval
Activation
Affect
affected
Analysis
analyzed
C‐reactive protein
control group
control groups
coronavirus disease
correlated
COVID‐19
COVID‐19 patient
COVID‐19
CRP
demographic data
died
elevated
Factor
fasting blood
ferritin
Final
Glucose
groups
Hospitalization
IL‐10
Inflammation
interquartile range
Laboratory results
lactate dehydrogenase
LDH
leukocyte
Macrophage
macrophages
Multiple
Patient
Pearson correlation
positively correlated
potential therapeutic target
Prognosis
prognostic indicator
reflect
Retrospective study
Serum ferritin
significantly higher
suggested
survival
Symptoms
TG level
Triglyceride
triglycerides
[DOI] 10.1002/iid3.469 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1002/iid3.469 PMC 바로가기 [Article Type] Original Article
The effect of tocilizumab on COVID-19 patient mortality: A systematic review and meta-analysis of randomized controlled trials
코로나19 환자 사망률에 대한 토실리주맙의 효과: 무작위 대조 시험의 체계적인 검토 및 메타 분석
Meta-Analysis
[키워드] 28-day mortality
95% CI
addition
Admission
AEs
assigned
benefit
clinical
Clinical efficacy
Cochrane Library
control group
control groups
COVID-19
COVID-19 patient
Efficacy and safety
eight
enrolled
Enrollment
help
ICU
ICU admission
Infection
initial
intensive care
mechanical ventilation
Meta-analysis
Mortality
no significant difference
Patient
patients with COVID-19
Placebo
Primary outcome
randomization
Randomized controlled trial
RCT
RCTs
receiving
reduce
registry
risk
Safe
SARS-CoV-2
searched
serious AE
Standard of care
subgroup analysis
survival
systematic review
Tocilizumab
Treatment
treatment group
treatment-emergent adverse event
two group
WHO
[DOI] 10.1016/j.intimp.2021.107602 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1016/j.intimp.2021.107602 PMC 바로가기 [Article Type] Meta-Analysis
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
Observational Study
[키워드] basal
BMI
body mass index
change
collected
conducted
Control
control group
control groups
coronavirus disease
COVID-19
COVID-19 lockdown
diabete
Effect
evaluated
Follow-up
glycaemic control
Healthcare provider
index
Italy
Lazio
lockdown
management
material
multicentre
no difference
Patient
Psychological
psychological health
Psychological well-being
resulting
Retrospective study
second wave
significantly
subject
T2D
type 2 diabete
type 2 diabetes
worsening
[DOI] 10.1111/dom.14380 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1111/dom.14380 PMC 바로가기 [Article Type] Observational Study
Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review
COVID-19 관리에서 렘데시비르의 효능, 효과 및 안전성을 평가하는 임상 연구: 범위 검토
Review
[키워드] accumulated
accumulating
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
adverse event
adverse events
Adverse reaction
Antiviral
association
clinical
Clinical improvement
clinical status
clinical trial
conducted
control groups
coronavirus
COVID
COVID 19
COVID-19
decreased mortality
Effectiveness
Efficacy
Efficacy and safety
Evidence
expected
GS 5734
hepatic impairment
Hospitalized
increased survival
Intervention
management
Median recovery time
observational studies
observational study
OVID
Participants
Patient
patients
patients with COVID-19
proportion
quantitative synthesis
randomized-controlled
Recovery time
Registered
Remdesivir
reported
Repurposed drug
Repurposed drugs
SARS-CoV-2
scoping review
searched
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe COVID-19
treat
treated
Treatment
Trial
trials
[DOI] 10.1111/bcp.14677 PMC 바로가기 [Article Type] Review
[DOI] 10.1111/bcp.14677 PMC 바로가기 [Article Type] Review